Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Microsulis Medical Ltd.
WARNING LETTER
•Microsulis Medical Ltd.•July 9, 2009

Microsulis Medical Ltd. – FDA Warning Letter, Jul 9, 2009

Record Details

An FDA inspection of Microsulis Medical Limited in Denmead, UK, from July 6-9, 2009, revealed that the firm's microwave endometrial and tissue ablation devices are adulterated under 21 U.S.C. 351(h). This is due to non-conformity with Current Good Manufacturing Practice (CGMP) requirements of the Quality System (QS) regulation, 21 CFR Part 820. The inspection identified several significant violations. The firm failed to establish and maintain adequate procedures for corrective and preventive actions (21 CFR 820.100(a)), including insufficient analysis of nonconforming products. Complaint handling procedures were inadequate (21 CFR 820.198), as returned products with performance issues were not entered into the complaint system. Deficiencies were also noted in design control, specifically regarding verifying design outputs against input requirements (21 CFR 820.30(f)) and validating device design to user needs and intended uses, including risk analysis (21 CFR 820.30(g)). While the firm's response to a design change procedure violation (21 CFR 820.30(i)) was adequate, procedures for quality audits (21 CFR 820.22) were found insufficient, with critical areas not being audited regularly. The firm's July 23, 2009, response was largely deemed inadequate, lacking specific corrective actions, systemic changes, or supporting documentation. Microsulis must promptly correct these violations and notify the FDA within 15 working days, providing a detailed plan, documentation, and a timetable. Failure to comply could result in device detention, impact on federal contracts, and denial of premarket approvals or Certificates to Foreign Governments. The FDA stressed that these issues may indicate broader systemic problems requiring thorough investigation.

Company
Microsulis Medical Ltd.
Inspection date
July 9, 2009
Product type
Devices
Office
Center for Devices and Radiological Health
People
  • Timothy A. Ulatowski (Director)
  • Paul F. Tilton
View Company Profile

ID · 66338b3b-a26e-4dd8-8fcc-2d76bff71b4a

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.100(a)21 CFR 820.19821 CFR 820.30(f)21 CFR 820.30(g)21 CFR 820.30(i)21 CFR 820.2221 U.S.C. 381(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Microsulis Medical Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.